CRSP earnings
CRISPR Therapeutics (CRSP) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CRSP earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | -0.94 | -1.19 | 21.01% | $10.18M |
| Q1 2026 | May 4, 2026 | -1.28 | -1.19 | -7.60% | $1.46M |
| Q4 2025 | Feb 12, 2026 | -1.37 | -1.15 | -19.13% | $864.00K |
| Q3 2025 | Nov 10, 2025 | -1.17 | -1.26 | 7.14% | $889.00K |
| Q2 2025 | Aug 5, 2025 | -2.40 | -1.47 | -63.27% | $892.00K |
| Q1 2025 | May 6, 2025 | -1.58 | -1.27 | -24.41% | $865.00K |
| Q4 2024 | Feb 11, 2025 | -0.44 | -1.15 | 61.74% | $35.00M |
| Q3 2024 | Nov 5, 2024 | -1.01 | -1.33 | 24.06% | $602.00K |
| Q2 2024 | Aug 5, 2024 | -1.49 | -1.37 | -8.76% | $517.00K |
| Q1 2024 | May 8, 2024 | -1.43 | -1.63 | 12.27% | $504.00K |
| Q4 2023 | Feb 21, 2024 | 1.10 | -0.07 | 1671.43% | $200.00M |
| Q3 2023 | Nov 6, 2023 | -1.41 | -1.98 | 28.79% | – |
| Aug 7, 2023 | -0.98 | -2.18 | 55.05% | – | |
| May 8, 2023 | -0.67 | -1.67 | 59.88% | – | |
| Feb 21, 2023 | -1.41 | -2.32 | 39.22% | – | |
| Nov 1, 2022 | -2.24 | -2.30 | 2.61% | – | |
| Aug 8, 2022 | -2.40 | -2.23 | -7.62% | – | |
| May 9, 2022 | -2.32 | -1.91 | -21.47% | – | |
| Feb 15, 2022 | -1.84 | -1.74 | -5.75% | – | |
| Nov 3, 2021 | -1.67 | -1.69 | 1.18% | – |
- CRSP beat EPS estimates in 18 of its last 40 reports.
Updated 2026-11-03 02:04 UTC